The cannabinoid based drug, licensed from Dolve Cann Global is the world’s first full-spectrum medicinal cannabis product (with less than 0.3% THC).
Neurotech International
ASX:NTI
Footer
Suite 5 CPC, 145 Stirling Highway
Nedlands WA 6009
Australia
+61 (8) 9389 3130